What does this research mean for the field?

Type II hyperlipoproteinemia, characterized by increased concentrations of normal-density beta-migrating lipoproteins, is clinically and genetically distinct from Type III hyperlipoproteinemia. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

January 26, 1967New England Journal of Medicine

Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders

View Full Paper

Ask AI

Bookmark

Design

Review

Authors

DFDonald S. FredricksonGeneral / Preventive / Lipids RLRobert I. LevyGeneral / Preventive / Lipids RLRobert S. LeesGeneral / Preventive / Lipids

Discussion

Member takes

Implication

Refines subtype distinction in lipid disorders; leaves open whether targeted interventions alter long-term outcomes.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fredrickson et al. (1967) studied this question.

synapsesocial.com/papers/6a1dcfbe5c054b78c2ef6902 https://doi.org/10.1056/nejm196701262760406

View Full Paper

Ask AI

Bookmark

Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders

Discussion

Member takes

Implication

Key Points

Cite This Study

Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider